Market Capitalization (Millions $) |
- |
Shares
Outstanding (Millions) |
33 |
Employees |
33 |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-65 |
Cash Flow (TTM) (Millions $) |
-2 |
Capital Exp. (TTM) (Millions $) |
0 |
Satsuma Pharmaceuticals Inc
Satsuma Pharmaceuticals Inc is a pharmaceutical company focused on the development and commercialization of novel drugs for the treatment of migraine. The company is dedicated to providing effective and convenient therapies to patients suffering from this neurological condition. Satsuma Pharmaceuticals aims to improve the lives of migraine sufferers by addressing unmet medical needs through innovative research, development, and commercialization strategies.
Company Address: 4819 Emperor Boulevard Durham 27703 NC
Company Phone Number: 410-3200 Stock Exchange / Ticker: NASDAQ STSA
|